Project Grant R01AR085631
- Federal Project Grant Award Summary The University of Pennsylvania received a $1,258,558 Project Grant awarded on September 5, 2025, by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports the development of a dual-action nanoparticle-loaded microparticle therapeutic platform designed to treat osteoarthritis (OA), a leading cause of disability in the United...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Pennsylvania $546,145 under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to conduct a five-year research project from May 1, 2026 through March 31, 2031. The project investigates the molecular mechanisms of telomere function in muscle cells, specifically focusing on how the telomeric protein TRF2 (telomeric repeat binding...
- Federal Grant Award Summary The University of Pennsylvania received a $719,758 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective July 10, 2025, with completion targeted for June 30, 2030. This award supports research investigating the nuclear functions of myotubularin (MTM1) protein and its role in muscle development and the pathogenesis of...
- Federal Project Grant Award Summary The University of Pennsylvania received a $507,606 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective June 1, 2026 through March 31, 2031. This research project investigates the mechanisms by which mechanical loading activates focal adhesion kinase (FAK)-mediated mechanotransduction in tendon cells within...
- Federal Grant Award Summary Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, received a $1.948 million Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) awarded on September 1, 2025, with a completion date of August 31, 2028. The grant funds research into post-transcriptional regulation of gene expression during bone...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Pittsburgh a $1.61 million Project Grant (CFDA 93.846: Arthritis, Musculoskeletal and Skin Diseases Research) beginning September 15, 2025, and concluding August 31, 2029. This research initiative examines the longitudinal associations between muscle characteristics and bone health preservation in older adults. The project leverages the Study of Muscle, Mobility...
- Federal Project Grant Award Summary The University of Pennsylvania received a $164,190 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded November 27, 2025, with completion scheduled for May 31, 2030. This award funds research investigating synovial mechanobiology as a therapeutic target for osteoarthritis (OA) disease mitigation. The project delivers scientific research products including in vitro studies examining the effects of...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the Regents of the University of Michigan a $1,317,880 Project Grant, effective September 19, 2025, through August 31, 2030, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award funds research to elucidate the mechanisms of bone remodeling in response to high metabolic demands associated with aerobic exercise, addressing a...
- Federal Project Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $221,484 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective July 1, 2025, through June 30, 2028. This award funds research investigating the molecular mechanisms governing skeletal patterning and cartilage growth plate development, specifically...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Virginia a $685,866 Project Grant effective August 15, 2025, through July 31, 2030, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This research initiative, titled "Leveraging Context-Specific eQTL to Inform BMD GWAS," focuses on identifying causal genes underlying bone mineral density (BMD)...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Trustees of the University of Pennsylvania a $2.3 million Project Grant on June 1, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This four-year research project, scheduled for completion by May 31, 2030, focuses on understanding osteocyte perilacunar-canalicular remodeling (PLR) mechanisms in maternal bone adaptation during and after pregnancy and lactation. The research leverages multiscale poroelastic modeling and investigational approaches to elucidate how lactation-induced activation of osteocyte PLR enlarges the lacunar-canalicular system and amplifies mechanical and biochemical signal transduction, thereby enhancing maternal bone's mechanical responsiveness and load-bearing capacity throughout the lifespan. The project will generate fundamental research outputs including mechanistic data on osteocyte-mediated bone remodeling processes, computational modeling results, and comparative analysis of bone microstructural adaptations in reproductive versus non-reproductive bone. The research will advance understanding of why lactation confers long-term protective benefits against bone loss associated with estrogen deficiency in later life, with potential implications for developing therapeutic strategies to mitigate reproduction-related and postmenopausal bone loss in women. Performance will be conducted at the University of Pennsylvania's facilities in Philadelphia, Pennsylvania.Federal Project Grant Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 6/10/26 | ||
| Not listed | $2.3m | 6/5/26 |